2017
DOI: 10.3904/kjim.2017.209
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Case-control and cohort studies have already shown that there is a significant dose-response relationship between serum HBV DNA levels measured at baseline and subsequent cirrhosis risk. Likewise, a similar relationship has been shown for the risk of hepatocellular carcinoma (HCC) (1)(2)(3)(4)(5). A strong correlation between the disease Giriş ve Amaç: Hepatit B virüsü nedeniyle siroz gelişen hastalarda Child-Pugh evresine göre HBV DNA düzeylerini karşılaştırmak.…”
Section: Introductionmentioning
confidence: 64%
See 1 more Smart Citation
“…Case-control and cohort studies have already shown that there is a significant dose-response relationship between serum HBV DNA levels measured at baseline and subsequent cirrhosis risk. Likewise, a similar relationship has been shown for the risk of hepatocellular carcinoma (HCC) (1)(2)(3)(4)(5). A strong correlation between the disease Giriş ve Amaç: Hepatit B virüsü nedeniyle siroz gelişen hastalarda Child-Pugh evresine göre HBV DNA düzeylerini karşılaştırmak.…”
Section: Introductionmentioning
confidence: 64%
“…Serum hepatitis B virus (HBV) DNA level has been previously shown to be an important and independent risk factor for the disease progression in chronic hepatitis B (1). Case-control and cohort studies have already shown that there is a significant dose-response relationship between serum HBV DNA levels measured at baseline and subsequent cirrhosis risk.…”
Section: Introductionmentioning
confidence: 99%
“…We appreciate the letter from Yanqing et al, 1 which raised several concerns about our study 2 . First, we definitely agree that serum hepatitis B s antigen (HBsAg) is significantly associated with the risk of hepatocellular carcinoma (HCC) development, as proven in REAVAL‐HBV and ERADICATE‐B studies 3 . In both studies, serum HBsAg and hepatitis B virus (HBV) DNA levels independently predicted the risk of HCC development.…”
mentioning
confidence: 78%